Physician

Brian Douglas Cheshire, M.D.

According to 2025 Medicare claims, Brian Cheshire, M.D. (NPI: 1366420382) practices dermatology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is BAY SHORE DERMATOLOGY, PC (NPI: 1316011398; TIN: 63-1119719) and primary practice location at 36532-3069.

Cheshire's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,023 traditional Medicare patients, billed 5,164 HCPCS/CPT codes, and received $234,350 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,282 prescription claims across 989 beneficiaries totaling $466,608 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 21 records totaling $491. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $397,435 to $234,350. In contrast, Part D prescription costs have risen steadily, from $180,073 to $466,608. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,452	8,124	$397,435
2016	1,483	7,630	$367,054
2017	1,334	7,017	$340,550
2018	1,310	8,823	$294,659
2019	1,380	8,511	$322,581
2020	1,155	7,777	$286,953
2021	1,317	9,171	$352,061
2022	1,084	6,327	$281,863
2023	1,089	5,864	$270,921
2024	1,023	5,164	$234,350

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	571	1,156	$180,073
2016	618	1,362	$238,159
2017	621	1,426	$330,640
2018	674	1,461	$301,684
2019	723	1,673	$353,404
2020	715	1,651	$335,761
2021	826	1,845	$469,579
2022	811	1,852	$461,234
2023	880	1,995	$331,791
2024	989	2,282	$466,608

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	178	194	$68
11102	Biopsy of related skin growth, first growth	314	363	$57
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	781	1,035	$53
17000	Destruction of precancer skin growth, 1 growth	561	740	$32
17003	Destruction of precancer skin growth, 2-14 growths	370	1,500	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	13	364	$110,939
Humira(Cf)	Adalimumab	13	364	$87,487
Dupixent Syringe	Dupilumab	14	392	$53,692
Fluocinonide	Fluocinonide	192	5,439	$9,672
Fluorouracil	Fluorouracil	84	2,425	$6,161

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$491	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Douglas Cheshire, M.D.?

Tedicare shows public-source Medicare data for Brian Douglas Cheshire, M.D. (NPI 1366420382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Douglas Cheshire, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Douglas Cheshire, M.D.?

Brian Douglas Cheshire, M.D. is linked to BAY SHORE DERMATOLOGY, PC (billing NPI 1316011398) in the available physician profile data.

Does Brian Douglas Cheshire, M.D. have Open Payments data?

Brian Douglas Cheshire, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.